Research articles
Clinical-Stage KRAS Therapeutics: How G12D and Pan-KRAS Strategies Are Reshaping Drug Development
Biopharma Launch Activity: New Molecular and Biologic Entities, 2021–2025
FDA Drug Approvals in 2025: What the Year’s 46 New Therapies Reveal About Industry Direction
Big Pharma M&A in 2025: A Shift Toward De-Risked Growth
Capital Efficiency in Chinese Biotech: A Comparative Analysis of Licensing Deal Structures
U.S. Pharma Manufacturing and R&D Site Investments Announced in 2025
Best-Selling Immunology Drugs in Q3 2025: Revenue Leaders and Market Dynamics
